5 results on '"Jean-Pierre Daurès"'
Search Results
2. Matching Graft Quality to Recipient’s Disease Severity Based on the Survival Benefit in Liver Transplantation
- Author
-
Jean-Pierre Daurès, Cyrille Feray, Audrey Winter, Daniel Azoulay, Corinne Antoine, Paul Landais, Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Clinique Beau Soleil [Montpellier], University of California [Los Angeles] (UCLA), University of California, Physiopathologie et traitement des maladies du foie, Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Agence de la biomédecine [Saint-Denis la Plaine], This work was funded by a grant of the French Ministry of Health and Social Affairs. The present study is part of the 'OPTIMATCH' program funded by the French Ministry of Health within the framework of the national Clinical Research Hospital Program., Bodescot, Myriam, and University of California (UC)
- Subjects
Adult ,Male ,Quality Control ,medicine.medical_specialty ,Epidemiology ,medicine.medical_treatment ,Population ,lcsh:Medicine ,030230 surgery ,Liver transplantation ,Gastroenterology ,Article ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Disease severity ,Internal medicine ,medicine ,Humans ,Prospective Studies ,education ,lcsh:Science ,education.field_of_study ,Multidisciplinary ,Proportional hazards model ,business.industry ,Liver Diseases ,Statistics ,Hazard ratio ,lcsh:R ,Patient Acuity ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,medicine.disease ,Survival Analysis ,[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Liver Transplantation ,3. Good health ,Transplantation ,body regions ,Survival benefit ,Liver cirrhosis ,Female ,030211 gastroenterology & hepatology ,lcsh:Q ,business ,Liver cancer - Abstract
Persistent shortage and heterogeneous quality of liver grafts encourages the optimization of donor-recipient matching in liver transplantation (LT). We explored whether or not there was a survival benefit (SB) of LT according to the quality of grafts assessed by the Donor Quality Index (DQI) and recipients’ disease severity, using the Model for End-Stage Liver Disease (MELD) in 8387 French patients wait-listed between 2009 and 2014. SB associated with LT was estimated using the sequential stratification method in different categories of MELD and DQI. For each transplantation, a stratum was created that matched one transplanted patient with all eligible control candidates. Strata were thereafter combined, and a stratified Cox model, adjusted for covariates, was fitted in order to estimate hazard ratios that qualified the SB according to each MELD and DQI sub-group. A significant SB was observed for all MELD and DQI sub-groups, with the exception of high MELD patients transplanted with “high-risk” grafts. More specifically, in decompensated-cirrhosis patients, “high-risk” grafts did not appear to be detrimental in medium MELD patients. Interestingly, in hepatocellular-carcinoma (HCC) patients, a significant SB was found for all MELD-DQI combinations. For MELD exceptions no SB was found. In terms of SB, “low-risk” grafts appeared appropriate for most severe patients (MELD > 30). Conversely, low/medium MELD and HCC patients presented an SB while allocated “high-risk” grafts. Thus, SB based matching rules for LT candidates might improve the survival of the LT population as a whole.
- Published
- 2020
3. A Donor Quality Index for liver transplantation: development, internal and external validation
- Author
-
Audrey Winter, Cyrille Feray, Etienne Audureau, Jean-Pierre Daurès, Paul Landais, Daniel Azoulay, and Corinne Antoine
- Subjects
Multidisciplinary ,Calibration (statistics) ,business.industry ,Proportional hazards model ,medicine.medical_treatment ,lcsh:R ,Renal function ,lcsh:Medicine ,Regression analysis ,030230 surgery ,Liver transplantation ,Intensive care unit ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Statistics ,Covariate ,medicine ,030211 gastroenterology & hepatology ,lcsh:Q ,Risk assessment ,business ,lcsh:Science - Abstract
Organ shortage leads to using non-optimal liver grafts. Thus, to determine the graft quality, the Donor Risk Index and the Eurotransplant Donor Risk Index have been proposed. In a previous study we showed that neither could be validated on the French database. Our aim was then dedicated to propose an adaptive Donor Quality Index (DQI) using data from 3961 liver transplantation (LT) performed in France between 2009 and 2013, with an external validation based on 1048 French LT performed in 2014. Using Cox models and three different methods of selection, we developed a new score and defined groups at risk. Model performance was assessed by means of three measures of discrimination corrected by the optimism using a bootstrap procedure. An external validation was also performed in order to evaluate its calibration and discrimination. Five donor covariates were retained: age, cause of death, intensive care unit stay, lowest MDRD creatinine clearance, and liver type. Three groups at risk could be discriminated. The performances of the model were satisfactory after internal validation. Calibration and discrimination were preserved in the external validation dataset. The DQI exhibited good properties and is potentially adaptive as an aid for better guiding decision making for LT.
- Published
- 2018
4. Author Correction: A Donor Quality Index for liver transplantation: development, internal and external validation
- Author
-
Etienne Audureau, Jean-Pierre Daurès, Cyrille Feray, Daniel Azoulay, Corinne Antoine, Paul Landais, and Audrey Winter
- Subjects
0301 basic medicine ,Male ,Quality Control ,medicine.medical_specialty ,Index (economics) ,Science ,media_common.quotation_subject ,medicine.medical_treatment ,Kaplan-Meier Estimate ,Liver transplantation ,Risk Assessment ,03 medical and health sciences ,medicine ,Humans ,Quality (business) ,Medical physics ,Author Correction ,media_common ,Aged ,Multidisciplinary ,business.industry ,External validation ,Prognosis ,Tissue Donors ,Liver Transplantation ,030104 developmental biology ,Creatinine ,Calibration ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Medicine ,Regression Analysis ,Female ,business - Abstract
Organ shortage leads to using non-optimal liver grafts. Thus, to determine the graft quality, the Donor Risk Index and the Eurotransplant Donor Risk Index have been proposed. In a previous study we showed that neither could be validated on the French database. Our aim was then dedicated to propose an adaptive Donor Quality Index (DQI) using data from 3961 liver transplantation (LT) performed in France between 2009 and 2013, with an external validation based on 1048 French LT performed in 2014. Using Cox models and three different methods of selection, we developed a new score and defined groups at risk. Model performance was assessed by means of three measures of discrimination corrected by the optimism using a bootstrap procedure. An external validation was also performed in order to evaluate its calibration and discrimination. Five donor covariates were retained: age, cause of death, intensive care unit stay, lowest MDRD creatinine clearance, and liver type. Three groups at risk could be discriminated. The performances of the model were satisfactory after internal validation. Calibration and discrimination were preserved in the external validation dataset. The DQI exhibited good properties and is potentially adaptive as an aid for better guiding decision making for LT.
- Published
- 2018
5. Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program
- Author
-
Emmanuel Bonnet, Jean-Pierre Daures, and Paul Landais
- Subjects
Medicine ,Science - Abstract
Abstract In France, more than 10 million women at ”average” risk of breast cancer (BC), are included in the organized BC screening. Existing predictive models of BC risk are not adapted to the French population. Thus, we set up a new score in the French Hérault region and looked for subgroups at a graded level of risk in women at ”average” risk. We recruited a retrospective cohort of women, aged 50 to 60, who underwent the organized BC screening, and included 2241 non-cancer women and 527 who developed a BC during a 12-year follow-up period (2006-2018). The risk factors identified were high breast density (ACR BI-RADS grading)(B vs A: HR = 1.41, 95%CI [1.05; 1.9], p = 0.023; C vs A: HR = 1.65 [1.2; 2.27], p = 0.02 ; D vs A: HR = 2.11 [1.25;3.58], p = 0.006), a history of maternal breast cancer (HR = 1.61 [1.24; 2.09], p < 0.001), and socioeconomic difficulties (HR 1.23 [1.09; 1.55], p = 0.003). While early menopause (HR = 0.36 [0.13; 0.99], p = 0.003) and an age at menarche after 12 years (HR = 0.77 [0.63; 0.95], p = 0.047) were protective factors. We identified 3 groups at risk: lower, average, and higher, respectively. A low threshold was characterized at 1.9% of 12-year risk and a high threshold at 4.5% 12-year risk. Mean 12-year risks in the 3 groups of risk were 1.37%, 2.68%, and 5.84%, respectively. Thus, 12% of women presented a level of risk different from the average risk group, corresponding to 600,000 women involved in the French organized BC screening, enabling to propose a new strategy to personalize the national BC screening. On one hand, for women at lower risk, we proposed to reduce the frequency of mammograms and on the other hand, for women at higher risk, we suggested intensifying surveillance.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.